Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROAD HF-AF
NCT03490994Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Apr 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Yonsei University. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03490994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03490994.